Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826488 · ClinicalTrials.gov registry record · Early Phase 1
A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 136
- Enrollment target
NCT00826488: Completed Early Phase 1 study, sponsored by Washington University School of Medicine.
NCT00826488 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 136 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (157% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00826488, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 136 participants
- Enrollment target
Study Summary
The purpose of this study is to compare conventional breast imaging and diagnostic work-up (2 dimensional imaging) to digital breast tomosynthesis (3 dimensional imaging) in the appearance of non-calcified breast masses. It is thought that non-calcified breast masses will be better visualized with the new 3D technology.
Interventions
- DEVICE Digital Breast Tomosynthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-12 |
| Phase | Early Phase 1 |
What the finished NCT00826488 record still lists
NCT00826488 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (157% higher).
The record links to 0 conditions, and to 1 intervention - of which Digital Breast Tomosynthesis is the first listed.
NCT00826488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00826488 about?
NCT00826488 is a clinical study titled "A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses". The purpose of this study is to compare conventional breast imaging and diagnostic work-up (2 dimensional imaging) to digital breast tomosynthesis (3 dimensional imaging) in the appearance of non-calcified breast masses. It is thought that non-calcified breast masses will be better visualized with t...
What is the current status of trial NCT00826488?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 136 participants. The study started on 2009-03. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00826488?
The interventions under investigation include: Digital Breast Tomosynthesis (DEVICE).
Who is sponsoring clinical trial NCT00826488?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00826488's enrollment target sits among peer trials
136 125th of 2000 higher than 1,874 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia